Peridinin, which is uniquely present in dinoflagellates, is one of the most abundant carotenoids found in nature. We evaluated the apoptotic effect of peridinin on DLD-1 human colorectal cancer cells. Peridinin significantly reduced the cell viability in a dose-dependent manner (0-20 M) and induced apoptosis by activating both caspase-8 and caspase-9. Our findings could be important for the high-performance utilization of marine bioproducts.
Carotenoids are pigments that are widely distributed in nature, from bacteria, yeast and algae to higher plants and animals. 1, 2) Peridinin, which is uniquely present in dinoflagellates, is an unusual carotenoid with epoxy, hydroxy and acetate groups on -rings, an allene moiety and a lactone group conjugated with the -electron system (Fig. 1A) . Pinto et al. have demonstrated peridinin to be the major singlet molecular oxygen quencher in marine algae. 3) Considering the biomass of marine organisms, peridinin is one of the most abundant carotenoids found in nature. We have previously evaluated fifteen dietary carotenoids for their effects on human prostate cancer cells, and reported that fucoxanthin and neoxanthin, which has a structure similar to fucoxanthin, markedly reduced cell viability by inducing apoptosis. 4) The allenic bond and 5,6-monoepoxide present in fucoxanthin and neoxanthin might be important for the induction of apoptosis. It is thus interesting to clarify the effect of peridinin on cancer cells, because its unique structure is different from that of other natural carotenoids including fucoxanthin and neoxanthin. In the present study, we evaluated the apoptotic effect on DLD-1 human colorectal cancer cells of peridinin prepared from the dinoflagellate, Heterocapsa triquetra, to extend our knowledge of its biological actions and its possible health benefits.
Cultures of the dinoflagellate, Heterocapsa triquetra, were grown in 2-3 liters of a modified SWM-3 medium under alternating 14 h of light (70-80 mEm À2 s À1 ) and 10 h of dark to a concentration of about 2 Â 10 5 cells/ ml. 5) After centrifugation at 2;000 Â g for 10 min, the pellet was lyophilized and stored at À80 C until needed. Carotenoid was extracted from the cells as described previously 6) and was applied to preparative silica TLC (Silica gel 60, Merck, Darmstadt, Germany) which was developed with hexane/acetone (7:3, v/v) to remove lipids. The carotenoid band was collected and extracted, and the peridinin-rich preparation was purified by HPLC.
7) The purified peridinin was confirmed by its positive ions recorded with an HPLC system connected to an LCQ mass spectrometer (Thermo Finnigan, San Jose, CA, USA) equipped with an interface of atmospheric pressure chemical ionization.
8) The characteristic ion peaks of peridinin at
) was used for quantification.
3)
The purity of peridinin was >99%, based on the peak at 475 nm in the HPLC analysis. The recovery of peridinin from the lyophilized cells was about 0.1% through the protocol just described. DLD-1 cells (JCRB9094, Human Science Research Resources Bank, Osaka, Japan) were cultured in an RPMI 1460 medium supplemented with 10% FBS and antibiotics. The cells were kept at 37 C under a humidified atmosphere containing 5% CO 2 . To evaluate the effect of peridinin on the viability of the DLD-1 cells, the cells were seeded in 96-well plates (100 ml/ well at a density of 2:0 Â 10 5 cells/ml). After incubating for 24 h, the medium was removed and the cells were cultured in a medium containing different doses of peridinin. Peridinin, dissolved in DMSO, was added to the culture medium to a final concentration of 5, 10 or 20 mM. The final concentration of DMSO in the culture medium was 0.1% (v/v), and the control culture y To whom correspondence should be addressed. Fax: +81-75-753-6212; E-mail: sugawara@kais.kyoto-u.ac.jp Biosci. Biotechnol. Biochem., 71 (4), [1069] [1070] [1071] [1072] 2007 Note received only 0.1% DMSO (vehicle alone). After 72 h of cultivation, the cell viability was evaluated by an MTT assay 9) and is expressed as the percentage of the control culture treated with the vehicle alone. To confirm the induction of apoptosis, DLD-1 cells were seeded at 5 Â 10 4 /well in 8-well chamber slides (Nunc, Naperville, IL, USA), and cultured for 48 h before the medium was changed to a medium containing 20 mM peridinin for a 48-h period, and then stained with 0.05% 4 0 ,6-diamidino-2-phenylindole.
10) The level of apoptotic cells treated with peridinin for 48 h was determined with a commercial kit (ssDNA Apoptosis ELISA kit, Chemicon International, Temecula, CA, USA) according to the manufacturer's instructions. This assay is based on the selective denaturation of DNA in apoptotic cells by formamide which detects denatured DNA by using a monoclonal antibody to single-stranded DNA. The caspase-8 and caspase-9 activities of the cells (1:0 Â 10 6 cells/well in 12-well plates) exposed to 20 mM peridinin for 48 h were measured by using colorimetric assay kits (Bio Vision, Mountain View, CA, USA) according to the manufacturer's instructions. Data are reported as the mean AE SD. Statistical analyses were performed by a one-way analysis of variance (ANOVA) with Scheffé's F test to identify the level of significance between groups.
Peridinin reduced the viability of DLD-1 human colon cancer cells in a dose-dependent manner after incubation for 72 h (Fig. 1B) . The apoptotic cells were evaluated by morphological changes: condensed chromatin fragments were seen under a fluorescence microscope after being stained with 4 0 ,6-diamidino-2-phenylindole subsequent to a treatment with 20 mM peridinin for 48 h (Fig. 2) . The level of apoptotic cells treated with peridinin for 48 h determined using a commercial kit was also significantly increased (Fig. 3A) . To elucidate the apoptotic mechanism induced by peridinin, we evaluated its effect on the caspase-8 and caspase-9 activities. The results show that caspase-8 was activated 2.4-fold and caspase-9 was activated 1.8-fold after 48 h of incubation of DLD-1 cells with peridinin (Fig. 3B) .
The present study demonstrates that peridinin, which has a unique structure different from fucoxanthin and neoxanthin, had an anti-proliferative effect on human colon cancer cells. This effect was due, at least in part, to apoptosis induced by peridinin. We observed that the activation of both caspase-8 and -9 occurred in the peridinin-induced apoptotic process. Activation of a caspase cascade is one of the key elements in the apoptotic process. Caspases-8 and -9 are involved in the death receptor pathway and in the mitochondrial pathway, respectively. However, caspase-8 can activate caspase-9 through the proteolysis of Bid, a member of the Bcl-2 protein family.
11) Thus, the induction of apoptosis by peridinin might have been mediated through the death receptor pathway. Das et al. have reported that fucoxanthin induced cell cycle arrest in colon cancer cells during the G0/G1 phase which was mediated through the up-regulation of p21WAF1/ Cip1.
12) The induction of apoptosis by peridinin might have been a subsequent event followed by cell cycle arrest. Further investigation is required to clarify the quantitative apoptotic effect and the detailed mechanism for apoptosis induction by peridinin.
Peridinin is ingested as a dietary component from some shellfish. 13, 14) Some parts of xanthophylls with their metabolites produced in the digestive tract would be absorbed in the jejunum, as suggested in previous studies, [6] [7] [8] while other parts would reach the colon through the intestinal tract. Peridinin might thereby work directly in the colon as a cancer-preventing agent against some types of colon carcinoma. However, the fate of dietary peridinin is still not well understood. The formation of fucoxanthinol from fucoxanthin has been demonstrated in human intestinal Caco-2 cells and in mice fed with fucoxanthin, and amarouciaxanthin A is generated from fucoxanthinol in the liver after intestinal absorption of fucoxanthinol. 7, 8) Therefore, dietary peridinin would be converted into deacetylated and further metabolized compounds in vivo. It will be important to characterize the absorption and metabolism of dietary peridinin in order to clarify its nutritional and therapeutic effects. 
